Although there was no significant correlation between CD36 and clinicopathologic characters such as age, gender, tumor size, differentiation or pathological stage (Supplementary Table 1), univariate and multivariate Cox regression analysis showed negative CD36 expression was associated with increased risk of death and was an independent risk factor for poorer overall survival after adjustment for risk factors including age and AJCC stage in patients with colon cancer, respectively (Supplementary Table 2). Here, CD36 is linked to malignant colon neoplasm.